Monday Takeaways: A Triple Threat of Tariffs, Tech, and Trading Pressure
Earnings season is heating up… as is Trump’s tariff war. Shah knows how to play it safe…
Dealmaker’s Diary: A Double Dose of Tickers
By reader request, Alpesh rates a cutting-edge biotech with 232% potential upside and a semiconductor giant with low volatility.
Buy This, Not That: What to Do After Nvidia’s Historic Drop
The market’s top semiconductor stock lost nearly $600 billion in market cap in a single day. But the chart tells us what we need to know.
Monday Takeaways: Chinese AI Rocks Markets
A new Chinese AI breakthrough sends tech stocks tumbling, just as we face a crucial week of mega-cap earnings and Fed decisions.
Dealmaker’s Diary: The Contrarian Play That Defies Market Logic
Despite industry headwinds and natural disasters, this $4.6 billion insurance company shows surprising strength. Our proprietary GVI analysis reveals why market fear creates your opportunity.
Monday Takeaways: A Strong Jobs Report Rattles Markets
A surprisingly strong jobs report and rising bond yields are creating market turbulence. Here’s what it means for your money…
Dealmaker’s Diary: An Energy Giant With 34.7% Upside
This energy stalwart, backed by Berkshire Hathaway’s 28% stake, is in perfect position for an energy boom.
Monday Takeaways: The First Test of 2025
Despite missing the Santa Claus rally, tech stocks are finding their footing again after a brief sell-off. But two key factors could impact this rally…
Dealmaker’s Diary: Is INOD a Buy?
This reader-submitted AI data-engineering company looks enticing with its $1 billion market cap and debt-free balance sheet. But is the stock’s momentum sustainable?
Monday Takeaways: The Year-End Rally Hits a Wall
Rising bond yields, mega-cap tech weakness, and mounting government debt paint a concerning picture for investors heading into 2025.